The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge with the biopharmaceutical industry. A variety of strategies are employed to antibody titer, comprising process parameter optimization, media optimization, and adoption of perfusion technologies. Fine-tuning culture conditions p